Absent tumor-suppressors allow melanoma to thwart immunotherapy
Thursday, March 2, 2017 - 15:01
in Health & Medicine
It’s what’s missing in the tumor genome, not what’s mutated, that thwarts treatment of metastatic melanoma with immune checkpoint blockade drugs, researchers report.